Found: 9
Select item for more details and to access through your institution.
Mucosal IFNλ1 mRNA-based immunomodulation effectively reduces SARS-CoV-2 induced mortality in mice.
- Published in:
- EMBO Reports, 2024, v. 25, n. 9, p. 3777, doi. 10.1038/s44319-024-00216-4
- By:
- Publication type:
- Article
Synergistic Highly Potent Targeted Drug Combinations in Different Pheochromocytoma Models Including Human Tumor Cultures.
- Published in:
- Endocrinology, 2019, v. 160, n. 11, p. 2600, doi. 10.1210/en.2019-00410
- By:
- Publication type:
- Article
Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 4, p. 1124, doi. 10.3390/ijms19041124
- By:
- Publication type:
- Article
The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0182852
- By:
- Publication type:
- Article
The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells.
- Published in:
- PLoS ONE, 2017, v. 12, n. 5, p. 1, doi. 10.1371/journal.pone.0178375
- By:
- Publication type:
- Article
GSK3α/β: A Novel Therapeutic Target for Neuroendocrine Tumors.
- Published in:
- Neuroendocrinology, 2018, v. 106, n. 4, p. 335, doi. 10.1159/000481887
- By:
- Publication type:
- Article
The Novel Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) Alone and in Dual-Targeting Approaches Demonstrates Antitumoral Efficacy in Neuroendocrine Tumors in vitro.
- Published in:
- Neuroendocrinology, 2017, v. 106, n. 1, p. 58, doi. 10.1159/000463386
- By:
- Publication type:
- Article
The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53<sup>wild type</sup> Neuroendocrine Tumor Cell Line GOT1.
- Published in:
- Neuroendocrinology, 2017, v. 106, n. 1, p. 1, doi. 10.1159/000453369
- By:
- Publication type:
- Article
Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0143830
- By:
- Publication type:
- Article